Belgian Pascal Goldschmidt aims to raise the profile of UM's community impact as dean of medical school
When John Clarkson resigned as the University of Miami's senior vice president for medical affairs and dean of the Miller School of Medicine to become executive director of the American Board of Ophthalmology, it took a yearlong search to find a successor. Chosen was Pascal J. Goldschmidt, an internationally renowned cardiologist and chairman of the prestigious department of medicine at Duke University Medical Center.
Announcing the appointment, which became effective April 6, UM President Donna Shalala described the Belgium native as "a first-rate leader and a wonderful researcher-clinician who will raise the Miller school to a spectacular new level of international medical and scientific leadership."
Dr. Goldschmidt, 52, a leading researcher in application of genomics and cell therapy to the prevention, diagnosis and treatment of coronary heart disease, is a former chief of Duke University's division of cardiology and director of cardiology at the Ohio State University College of Medicine and Public Health, where he founded the Heart and Lung Institute.
He has come to UM at a time of major expansion - construction of the Clinical Research Institute is nearing completion and plans are under way for a university hospital and a biomedical research institute. In his new role, he oversees an annual budget of $900 million and a staff of more than 7,000, including 1,100 full-time faculty members.
Dr. Goldschmidt was interviewed at his office in the Rosenstiel Medical Science Building by Miami Today international editor Michael Hayes.
This is an excerpt from the weekly profile article published in Miami Today. To read the entire article in full, order this issue or subscribe to the print edition of Miami Today.